GastroGard 370 mg/g oral paste
GastroGard 370 mg/g oral paste
Authorised
This information is not available for this product.
Product identification
Medicine name:
GastroGard 370 mg/g oral paste
Gastrogard 370 mg/g oralpasta
Active substance:
This information is not available for this product.
Target species:
-
Horse
Route of administration:
-
Oral use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Oral paste
Withdrawal period by route of administration:
-
Oral use
- Horse
-
Meat and offal1day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA02BC01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Norway
Package description:
- Immediate packaging: 10 ml syringe containing 6.16 g of paste composed of white polypropylene syringes barrel with a white LDPE cap, a rubber rod tip and a polypropylene plunger rod, with dose divisions calibrated by body weight.Outer packaging and sales presentations-Bulk pack of 72 syringes
- Immediate packaging: 10 ml syringe containing 6.16 g of paste composed of white polypropylene syringes barrel with a white LDPE cap, a rubber rod tip and a polypropylene plunger rod, with dose divisions calibrated by body weight.Outer packaging and sales presentations-Carton box of 14 syringes
- Immediate packaging: 10 ml syringe containing 6.16 g of paste composed of white polypropylene syringes barrel with a white LDPE cap, a rubber rod tip and a polypropylene plunger rod, with dose divisions calibrated by body weight.Outer packaging and sales presentations-Carton box of 7 syringes
- Immediate packaging: 10 ml syringe containing 6.16 g of paste composed of white polypropylene syringes barrel with a white LDPE cap, a rubber rod tip and a polypropylene plunger rod, with dose divisions calibrated by body weight.Outer packaging and sales presentations-Carton box of 1 syringe
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Denmark A/S
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Norwegian Medical Products Agency
Authorisation number:
- 10-8043
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0489/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Italy
-
Luxembourg
-
Netherlands
-
Norway
-
Portugal
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 11/02/2022
Norwegian (PDF)
Published on: 27/04/2023
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 27/04/2023
How useful was this page?: